Neuropathy and Efficacy Of Weekly Subcutaneous Bortezomib In Myeloma and AL Amyloidosis

被引：1
|
作者：
Sidana, Surbhi
Faiman, Beth
Elson, Paul
Smith, Mitchell R.
Dean, Robert M.
Valent, Jason
Samaras, Christy
Duong, Hien K.
Hastings, Debbie
Bruening, Kellie
Reu, Frederic J.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1975.1975
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1975
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis
    Sidana, Surbhi
    Narkhede, Mayur
    Elson, Paul
    Hastings, Debbie
    Faiman, Beth
    Valent, Jason
    Samaras, Christy
    Hamilton, Kimberly
    Liu, Hien K.
    Smith, Mitchell R.
    Reu, Frederic J.
    [J]. PLOS ONE, 2017, 12 (03):
  • [2] Safety and Efficacy of Once Weekly Subcutaneous Bortezomib in Advanced Stage AL Amyloidosis
    Bumma, Naresh
    Reu, Frederic J.
    Samaras, Christy
    Duong, Hien K.
    Smith, Mitchell R.
    Valent, Jason
    [J]. BLOOD, 2014, 124 (21)
  • [3] RVD with weekly subcutaneous bortezomib minimizes neuropathy and maintains efficacy in a diverse multiple myeloma cohort
    Gill, Amitoj
    Jayswal, Rani
    Weiss, Heidi
    Rhodes, Jill
    Hegazi, Mohamed
    Herzig, Geoffrey
    Herzig, Roger
    Krem, Maxwell
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E210 - E210
  • [4] Once Weekly Subcutaneous Bortezomib, Cyclophosphamide, and Dexamethasone As Induction Therapy for All AL Amyloidosis
    Abbas, Hashim
    Rybicki, Lisa A.
    Reu, Frederic J.
    Samaras, Christy
    Smith, Mitchell R.
    Hastings, Debbie
    Valent, Jason
    [J]. BLOOD, 2016, 128 (22)
  • [5] Comparing neuropathy in multiple myeloma and AL amyloidosis
    Ballegaard, Martin
    Nelson, Laerke Marie
    Gimsing, Peter
    [J]. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2021, 26 (01) : 75 - 82
  • [6] Peripheral neuropathy outcomes and efficacy of subcutaneous bortezomib when combined with thalidomide and dexamethasone in the treatment of multiple myeloma
    Liu, Hong
    Xu, Ruirong
    Huang, Hongming
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (05) : 3041 - 3046
  • [7] Weekly and twice-weekly bortezomib in AL amyloidosis: Results of a phase II study
    Reece, D. E.
    Hegenbart, U.
    Sanchorawala, V.
    Merlini, G.
    Blade, J.
    Liu, K.
    Enny, C.
    Van de Velde, H.
    Cakana, A.
    Comenzo, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis
    Lamm, W.
    Willenbacher, W.
    Lang, A.
    Zojer, N.
    Muelduer, E.
    Ludwig, H.
    Schauer-Stalzer, B.
    Zielinski, C. C.
    Drach, J.
    [J]. ANNALS OF HEMATOLOGY, 2011, 90 (02) : 201 - 206
  • [9] Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis
    W. Lamm
    W. Willenbacher
    A. Lang
    N. Zojer
    E. Müldür
    H. Ludwig
    B. Schauer-Stalzer
    C. C. Zielinski
    J. Drach
    [J]. Annals of Hematology, 2011, 90 : 201 - 206
  • [10] Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis
    Lamm, W.
    Willenbacher, W.
    Lang, A.
    Zojer, N.
    Muelduer, E.
    Ludwig, H.
    Zielinski, C. C.
    Drach, J.
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 192 - 193
12345